Vitlife

UPADACITINIB (RINVOQ®) AND VITILIGO: UPDATE ON A POTENTIAL NEW SYSTEMIC TREATMENT

Share this article →
 
 
Close

Search articles

Upadacitinib (RINVOQ®) and Vitiligo: Update on a Potential New Systemic Treatment

 Posted on 10th February 2026  2 minute read

Sorry, but you do not have permission to view this content.

Please support our work! You've enjoyed 1 article this month and we hope you have found it useful. Our work is entirely funded by memberships and donations, so please consider joining our charity today and supporting our work.

Become a Member